CD4-Positive T-Lymphocytes
"CD4-Positive T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
Descriptor ID |
D015496
|
MeSH Number(s) |
A11.118.637.555.567.569.200 A15.145.229.637.555.567.569.200 A15.382.490.555.567.569.200
|
Concept/Terms |
CD4-Positive T-Lymphocytes- CD4-Positive T-Lymphocytes
- CD4 Positive T Lymphocytes
- CD4-Positive T-Lymphocyte
- T-Lymphocyte, CD4-Positive
- T-Lymphocytes, CD4-Positive
- CD4-Positive Lymphocytes
- CD4-Positive Lymphocyte
- Lymphocyte, CD4-Positive
- Lymphocytes, CD4-Positive
- T4 Cells
- T4 Cell
- T4 Lymphocytes
- T4 Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "CD4-Positive T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "CD4-Positive T-Lymphocytes".
This graph shows the total number of publications written about "CD4-Positive T-Lymphocytes" by people in this website by year, and whether "CD4-Positive T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 6 | 10 |
1995 | 5 | 8 | 13 |
1996 | 4 | 3 | 7 |
1997 | 3 | 4 | 7 |
1998 | 1 | 6 | 7 |
1999 | 3 | 4 | 7 |
2000 | 1 | 7 | 8 |
2001 | 3 | 4 | 7 |
2002 | 9 | 8 | 17 |
2003 | 12 | 11 | 23 |
2004 | 9 | 12 | 21 |
2005 | 17 | 11 | 28 |
2006 | 13 | 11 | 24 |
2007 | 14 | 15 | 29 |
2008 | 18 | 13 | 31 |
2009 | 18 | 15 | 33 |
2010 | 12 | 15 | 27 |
2011 | 15 | 18 | 33 |
2012 | 16 | 12 | 28 |
2013 | 18 | 11 | 29 |
2014 | 12 | 18 | 30 |
2015 | 9 | 10 | 19 |
2016 | 13 | 9 | 22 |
2017 | 13 | 11 | 24 |
2018 | 13 | 13 | 26 |
2019 | 6 | 9 | 15 |
2020 | 8 | 16 | 24 |
2021 | 3 | 11 | 14 |
2022 | 2 | 9 | 11 |
2023 | 1 | 7 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD4-Positive T-Lymphocytes" by people in Profiles.
-
Latent human herpesvirus 6 is reactivated in CAR T cells. Nature. 2023 Nov; 623(7987):608-615.
-
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. J Immunother Cancer. 2023 10; 11(10).
-
Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms. Front Immunol. 2023; 14:1167965.
-
Clinicopathologic Features of Severe Acute Hepatitis Associated With Adenovirus Infection in Children. Am J Surg Pathol. 2023 09 01; 47(9):977-989.
-
Reduced CCR5 expression among Uganda HIV controllers. Retrovirology. 2023 05 25; 20(1):8.
-
Relationships between T-lymphocytes and physical function in adults with chronic lymphocytic leukemia: Results from the HEALTH4CLL pilot study. Eur J Haematol. 2023 Jun; 110(6):732-742.
-
Sialokinin in mosquito saliva shifts human immune responses towards intracellular pathogens. PLoS Negl Trop Dis. 2023 02; 17(2):e0011095.
-
Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy. Nat Cancer. 2023 02; 4(2):222-239.
-
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses. PLoS One. 2023; 18(1):e0280364.
-
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J Allergy Clin Immunol. 2023 02; 151(2):539-546.